Valuation : Sartorius AG

Market Cap 14.42B 16.72B 13.65B 12.36B 23.19B 1,598B 23.32B 162B 62.31B 812B 62.8B 61.41B 2,569B P/E 2026 *
61.1x
P/E 2027 * 47.3x
Enterprise Value 17.99B 20.87B 17.04B 15.43B 28.94B 1,994B 29.1B 202B 77.76B 1,013B 78.37B 76.64B 3,205B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.33x
Free-Float
35.87%
Yield 2026 *
0.34%
Yield 2027 * 0.42%
1 day-2.16%
1 week-5.24%
Current month-8.12%
1 month-3.72%
3 months-0.55%
6 months+8.38%
Current year-2.16%
1 week 36.2
Extreme 36.2
37.6
1 month 36.2
Extreme 36.2
39.4
Current year 31.6
Extreme 31.6
40.2
1 year 30.8
Extreme 30.8
40.2
3 years 29
Extreme 29
55
5 years 29
Extreme 29
155
10 years 29
Extreme 29
174
Manager TitleAgeSince
Chief Executive Officer 59 29/06/2025
Director of Finance/CFO 55 31/03/2024
Chief Operating Officer 70 31/12/2000
Director TitleAgeSince
Director/Board Member 62 31/08/2002
Chairman 69 18/07/2017
Director/Board Member 77 28/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-5.24% - - 16.65B
+0.87%-4.86%+16.71%-33.27% 16.65B
-1.77%+7.05%-31.49%+58.12% 1.78B
+0.08%-3.83%-28.36%+19.34% 894M
-3.05%-15.43%-57.37%-84.22% 833M
-0.05%-0.32%+68.43%-3.30% 778M
-2.56%-5.08%-37.23%-49.60% 654M
-5.26%-9.30%-44.97%-48.89% 591M
+3.41%-15.78%-44.42%-39.91% 436M
+1.82%-5.18%+67.02%+48.52% 386M
Average -0.87%-6.09%-10.19%-14.80% 2.56B
Weighted average by Cap. -0.75%-4.95%+6.86%-24.59%

Financials

2026 *2027 *
Net sales 3.72B 4.32B 3.52B 3.19B 5.99B 412B 6.02B 41.84B 16.08B 210B 16.21B 15.85B 663B 4.08B 4.73B 3.86B 3.5B 6.56B 452B 6.6B 45.88B 17.63B 230B 17.77B 17.38B 727B
Net income 255M 296M 242M 219M 411M 28.3B 413M 2.87B 1.1B 14.38B 1.11B 1.09B 45.5B 328M 381M 311M 282M 528M 36.4B 531M 3.69B 1.42B 18.5B 1.43B 1.4B 58.52B
Net Debt 3.58B 4.15B 3.38B 3.07B 5.75B 396B 5.78B 40.2B 15.45B 201B 15.57B 15.23B 637B 3.27B 3.79B 3.1B 2.8B 5.26B 362B 5.29B 36.77B 14.13B 184B 14.24B 13.93B 582B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change
11/09/26 €36.20 -2.16%
10/09/26 €37.00 +0.54%
09/09/26 €36.80 0.00%
08/09/26 €36.80 -2.13%
07/09/26 €37.60 -2.08%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
232.90EUR
Average target price
271.74EUR
Spread / Average Target
+16.68%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!